Scientific News Thermo Fisher Scientific Nyse Tmo Has A Pretty Healthy Balance Sheet
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Thermo Fisher Scientific Nyse Tmo Has A Pretty Healthy Balance Sheet is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Examining the Future: Thermo Fisher Scientific's Earnings Outlook
Analysts estimate that Thermo Fisher Scientific will report an earnings per share (EPS) of $5.50. The announcement from Thermo Fisher Scientific is eagerly anticipated, with investors seeking news of ... Read More
J.P. Morgan Raises PT on Thermo Fisher Scientific (TMO) Keeps an Overweight Rating
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the Best Forever Stocks to Invest In Now. On October 9, J.P. Read More
Thermo Fisher Scientific's Options Frenzy: What You Need to Know
In terms of liquidity and interest, the mean open interest for Thermo Fisher Scientific options trades today is 604.81 with a total volume of 20,341.00. Read More
OpenAI and Thermo Fisher Scientific in Life Sciences Collaboration
Thermo Fisher Scientific Inc. (NYSE: TMO) announced AI utilization plans with OpenAI in a collaboration intended to improve drug - Read more from Inside HPC & AI News. Read More
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Thermo Fisher Scientific (TMO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known ... Read More
Polen Focus Growth Strategy Sold Thermo Fisher Scientific (TMO) to Fund Other Investments
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Read More
Here’s Why Thermo Fisher Scientific (TMO) Traded Lower in Q2
Loomis Sayles, an investment management company, released its “Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund returned ... Read More
Franklin Street Loads Up on Thermo Fisher Scientific (NASDAQ:TMO): Becomes 8th Largest Holding
Franklin Street Advisors' purchase of Thermo Fisher Scientific is notable as the firm grew the stock's portfolio allocation from 0.4% to 2.9%, making the company its 8th-largest holding. Read More
Thermo Fisher: A Hold For Stability, Not For Outperformance
Thermo Fisher Scientific is a high-quality, defensive investment with a strong moat but faces revenue growth headwinds and limited upside. TMO reported solid Q2 2025 results with a double-beat, but ... Read More
Behind the Scenes of Thermo Fisher Scientific's Latest Options Trends
Financial giants have made a conspicuous bullish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific (NYSE:TMO) revealed 49 unusual trades. Delving into the ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus